AGM Meeting Clarification
February 22 2008 - 3:40AM
UK Regulatory
RNS Number:5384O
Arana Therapeutics Limited
22 February 2008
FOR IMMEDIATE RELEASE 22 FEBRUARY 2007
Arana Therapeutics Limited
Annual General Meeting Clarification
Re-election as a Director not sought by Dr Phil Jennings
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer advises that Dr Phil Jennings is no longer a Director of
Arana, with effect from the close of the Company's Annual General Meeting held
on 14 February 2008. Dr Jennings' term as Director was scheduled to conclude by
reason of rotation in accordance with clause 6.3 of the Company's Constitution
and, while being eligible for re-election as a Director of the Company, did not
seek re-election as a Director. Dr Jennings continues in his executive role with
the Company as Chief Scientific Officer.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSEMSAESASEDE
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From May 2024 to Jun 2024
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From Jun 2023 to Jun 2024